Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (114)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by COWAN, L. D.
Right arrow Articles by JONES, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by COWAN, L. D.
Right arrow Articles by JONES, G. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 114, No. 2: 209-217
Copyright © 1981 by The Johns Hopkins University School of Hygiene and Public Health


research-article

BREAST CANCER INCIDENCE IN WOMEN WITH A HISTORY OF PROGESTERONE DEFICIENCY

LINDA D. COWAN1, LEON GORDIS1, JAMES A. TONASCIA1,2 and GEORGEANNA SEEGAR JONES3

1Department of Epidemiology, School of Hygiene and Public Health, The Johns Hopkins University Baltimore, MD.
2Department of Biostatistics, School of Hygiene and Public Health, The Johns Hopkins University
3Department of Obstetrics and Gynecology, The Johns Hopkins School of Medicine.

In order to investigate the nature of the association of involuntarily delayed first birth and risk of breast cancer, 1083 white women who had been evaluated and treated for infertility from 1945–1965 were followed prospectively through April 1978 to ascertain their breast cancer incidence. These women were categorized as to the cause of infertility into two groups, those with endogenous progesterone deficiency (PD) and those with nonhormonal causes (NH). Women in the PD group had 5.4 times the risk of premenopausal breast cancer compared to women in the NH group. This excess risk could not be explained by differences between the two groups in ages at menarche or menopause, history of oral contraceptive use, history of benign breast dis ease or age at first birth. Women in the PD group also experienced a 10-fold increase in deaths from all malignant neopiasms compared to the NH group. The Incidence of postmenopausal breast cancer did not differ significantly between the two groups.

breast neoplasms; fertility; progesterone


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch Intern MedHome page
K. L. Terry, W. C. Willett, J. W. Rich-Edwards, and K. B. Michels
A Prospective Study of Infertility Due to Ovulatory Disorders, Ovulation Induction, and Incidence of Breast Cancer
Arch Intern Med, December 11, 2006; 166(22): 2484 - 2489.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. A. Brinton, B. Scoccia, K. S. Moghissi, C. L. Westhoff, M. D. Althuis, J. E. Mabie, and E. J. Lamb
Breast cancer risk associated with ovulation-stimulating drugs
Hum. Reprod., September 1, 2004; 19(9): 2005 - 2013.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Ricci, F. Parazzini, E. Negri, S. Marsico, and C. La Vecchia
Fertility drugs and the risk of breast cancer
Hum. Reprod., June 1, 1999; 14(6): 1653 - 1655.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. De Souza, B. E. Miller, A. B. Loucks, A. A. Luciano, L. S. Pescatello, C. G. Campbell, and B. L. Lasley
High Frequency of Luteal Phase Deficiency and Anovulation in Recreational Women Runners: Blunted Elevation in Follicle-Stimulating Hormone Observed during Luteal-Follicular Transition
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4220 - 4232.
[Abstract] [Full Text]


Home page
Arch Fam MedHome page
R. D. Gambrell Jr
Hormone Replacement Therapy and Breast Cancer Risk
Arch Fam Med, June 1, 1996; 5(6): 341 - 348.
[Abstract] [PDF]


Home page
BMJHome page
K McPherson, C M Steel, J M Dixon, and W R Miller
Risk factors for breast cancer
BMJ, March 4, 1995; 310(6979): 598b - 598.
[Full Text]


Home page
BMJHome page
P. J Lewis
Pollutants and pesticides may be important
BMJ, December 17, 1994; 309(6969): 1662a - 1662.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.